首页> 外国专利> METHOD FOR PREDICTING METASTASIS OF ORAL CAVITY CANCER TO CERVICAL LYMPH NODE AND DIAGNOSTIC KIT USED FOR THE PREDICTION

METHOD FOR PREDICTING METASTASIS OF ORAL CAVITY CANCER TO CERVICAL LYMPH NODE AND DIAGNOSTIC KIT USED FOR THE PREDICTION

机译:预测用于预测口腔淋巴结转移的宫颈癌和诊断工具的方法

摘要

PPROBLEM TO BE SOLVED: To provide a method for predicting possibility of a cervical lymph node metastasis of each symptom diagnosed as an oral cavity cancer in early stages and objectively. PSOLUTION: The method for predicting metastasis of an oral cavity cancer to a cervical lymph node comprises a process for assaying an expression amount of metastasis prediction gene group in which an expression amount changes between a metastasis group composed of cases of metastasis of an oral cavity cancer to a cervical lymph node and a nonmetastasis group composed cases of nonmetastasis for samples collected from a primary lesion of an oral cavity cancer and a process for predicting the possibility of metastasis of an oral cavity cancer to a cervical lymph node by comparing the expression amount of the metastasis prediction gene group with the expression amount of the metastasis prediction gene in a metastasis group and/or a nonmetastasis group. The metastasis prediction gene group comprises two groups of MSR1(NM_138716.1) and RET(M31213.1). PCOPYRIGHT: (C)2008,JPO&INPIT
机译:

要解决的问题:提供一种方法来客观,客观地预测诊断为口腔癌的每种症状的颈淋巴结转移的可能性。

解决方案:预测口腔癌转移至宫颈淋巴结的方法包括测定转移预测基因组表达量的方法,其中表达量在由癌转移病例组成的转移组之间改变。口腔癌至宫颈淋巴结和非转移组包括从口腔癌原发灶采集的样本的非转移病例,以及通过比较口腔癌转移至宫颈淋巴结的可能性的过程转移预测基因组的表达量与转移组和/或非转移组中转移预测基因的表达量。转移预测基因组包括两组MSR1(NM_138716.1)和RET(M31213.1)。

版权:(C)2008,日本特许厅&INPIT

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号